Development and validation of LC-MS method with electro spray ionization for quantitation of sumatriptan in human plasma: Application to bioequivalence study
Анотація
Slavica Vučinić, Dragana Đorđević Sumatriptan is a potent and selective vascular 5-hydroxytryptamine1 (5-HT1) receptor agonist effective for the treatment of migraine. We developed liquid chromatographic-mass spectrometric method for de-termination of sumatriptan in human plasma. Sumatriptan was extracted from samples using solid phase extraction technique and separated on analytical column, Waters ODS2, thermostated at 20°C. The mobile phase was a mixture of 5mM ammonium-acetate and acetonitrile (80:20), with a flow rate of 0.3 mL/min. Total run time was 10 min. Mass spectral detector was optimized and adjusted in elec-trospray single ion monitoring (ESI-SIR) mode. Molecular ion masses (m/z) were 296.00 and 267.00 for sumatriptan and internal standard atenolol, respectively. Under these conditions retention times for inter-nal standard atenolol and sumatriptan, were 3.4 ± 0.3 min and 7.3 ± 0.5 min, respectively. The standard curve of plasma spiked with sumatriptan was linear in the range of 1.0-100.0 ng/mL, with correlation coefficient r = 0.9931. The limit of quantification (LOQ) was 1.0 ng/mL. Presented method was successfully applied in the pharmacokinetic study of generic tablets with the new formulation, con-taining sumatriptan, after single oral dose (100 mg) was given to 24 volunteers. This method is simple, sensitive and suitable for pharmacokinetic or bioequivalence studies.
Як цитувати
Dragana Rančić, Snežana Đorđević, Slavica Vučinić, Dragana Đorđević. Development and validation of LC-MS method with electro spray ionization for quantitation of sumatriptan in human plasma: Application to bioequivalence study. Methods Objects Chem. Anal. 2013, 8(4), 207-213.